PP
DTIL icon

PDT Partners’s Precision BioSciences DTIL Stock Holding History

PDT Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-734
Closed -$68K – 1003
2022
Q1 		$68K Sell
734
-8
-1% -$1.09K 0.01% 888
2021
Q4 		$165K Sell
742
-1,413
-66% -$395K 0.01% 785
2021
Q3 		$746K Sell
2,155
-1,395
-39% -$473K 0.05% 400
2021
Q2 		$1.33M Sell
3,550
-779
-18% -$234K 0.09% 324
2021
Q1 		$1.34M Buy
4,329
+3,592
+487% +$1.26M 0.1% 315
2020
Q4 		$184K Sell
737
-83
-10% -$20.3K 0.01% 615
2020
Q3 		$151K Sell
820
-213
-21% -$42.4K 0.01% 658
2020
Q2 		$258K Sell
1,033
-166
-14% -$36.4K 0.02% 550
2020
Q1 		$217K Buy
+1,199
New +$314K 0.02% 547

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PDT Partners's DTIL Position: Q2 2022 in Review

PDT Partners sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 734 shares — an estimated $68K sold.

PDT Partners first reported a position in DTIL in Q1 2020 and held it in 9 quarters. The position peaked at $1.34M in Q1 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • PDT Partners reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • PDT Partners sold 734 Precision BioSciences shares in Q2 2022, an estimated $68K.
  • PDT Partners first reported a position in Precision BioSciences in Q1 2020 and held it in 9 quarters.
  • PDT Partners's Precision BioSciences position peaked at $1.34M in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.